Home » Topics » BioWorld Science

BioWorld Science
RSS

Vanadium compounds for treatment of diabetes

Aug. 8, 1997

Tacrine analogs reported for Alzheimer's disease

Aug. 8, 1997

Theratechnologies: Q2 1997 highlights

Aug. 8, 1997

Aquila issued patent covering potent drug delivery agents

Aug. 8, 1997

Protein kinase C inhibitors discovered at Cephalon

Aug. 8, 1997

First approval for Elan's Diastat

Aug. 8, 1997

SKB reports new agents for atherosclerosis

Aug. 8, 1997

Update on Proleukin regulatory status; Photofrin approved in Germany

Aug. 8, 1997

Matrix and Savage enter marketing agreement for AccuSite

Aug. 8, 1997

Medtronic's therapy for urinary incontinence recommended for approval by FDA panel

Aug. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...